Guizhou Yibai Pharmaceutical Co Ltd Class A 600594
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Trading Information
- Previous Close Price
- ¥3.57
- Day Range
- ¥3.55–3.90
- 52-Week Range
- ¥2.76–6.15
- Bid/Ask
- ¥3.80 / ¥3.81
- Market Cap
- ¥3.02 Bil
- Volume/Avg
- 43.2 Mil / 9.2 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 1.20
- Dividend Yield (Trailing)
- 1.73%
- Dividend Yield (Forward)
- 1.73%
- Total Yield
- 1.73%
Company Profile
Guizhou Yibai Pharmaceutical Co Ltd engages in the research, development, production, and sale of pharmaceutical products in China. Its products include tumor, cardio-cerebral vascular, respiratory system, anti-rheumatic, digestive system, pediatric, gynecological, andrological, anti-infection, anti-inflammatory, analgesic, tonic, and other drugs.
- Sector
- Healthcare
- Industry
- Drug Manufacturers - Specialty & Generic
- Stock Style Box
- Small Value
- Total Number of Employees
- 5,509
- Website
- http://www.gzcci.com
Comparables
Valuation
|
Metric
|
600594
|
600216
|
000739
|
|---|---|---|---|
Price/Earnings (Normalized) | — | 68.87 | 20.02 |
Price/Book Value | 1.11 | 1.67 | 3.18 |
Price/Sales | 1.20 | 1.98 | 1.69 |
Price/Cash Flow | 14.04 | 16.04 | 10.59 |
Price/Earnings
600594
600216
000739
Financial Strength
|
Metric
|
600594
|
600216
|
000739
|
|---|---|---|---|
Quick Ratio | 1.21 | 1.68 | 0.97 |
Current Ratio | 1.82 | 2.66 | 1.30 |
Interest Coverage | −3.36 | 15.43 | 35.39 |
Quick Ratio
600594
600216
000739
Profitability
|
Metric
|
600594
|
600216
|
000739
|
|---|---|---|---|
Return on Assets (Normalized) | −3.17% | 1.81% | 7.96% |
Return on Equity (Normalized) | −5.06% | 2.37% | 16.93% |
Return on Invested Capital (Normalized) | −3.17% | 2.20% | 13.55% |
Return on Assets
600594
600216
000739
Drug Manufacturers - Specialty & Generic Industry Comparables
|
1-Day Chart
|
Name
|
Price
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|---|
| Zoetis Inc Class A
ZTS
| Wfjyywhdxt | Fbzg | $86.5 Bil | |||
| Merck KGaA ADR
MKKGY
| Jlwnjxhrz | Scdpbp | $75.2 Bil | |||
| Haleon PLC ADR
HLN
| Dxnpyjtw | Zgdp | $46.6 Bil | |||
| Teva Pharmaceutical Industries Ltd ADR
TEVA
| Mhjnqqkbz | Jjdj | $19.9 Bil | |||
| Viatris Inc
VTRS
| Lchvyvh | Zlf | $13.6 Bil | |||
| Dr Reddy's Laboratories Ltd ADR
RDY
| Bhlrvrj | Rsxp | $13.4 Bil | |||
| Catalent Inc
CTLT
| Ntlbrqkn | Wyydcqc | $11.0 Bil | |||
| Prestige Consumer Healthcare Inc
PBH
| Ylfchqwkn | Cjbql | $3.4 Bil | |||
| Perrigo Co PLC
PRGO
| Mzgtpblm | Zmbkn | $3.4 Bil | |||
| Green Thumb Industries Inc
GTBIF
| Kpfxffltw | Yxb | $2.5 Bil |
United States